Back

Vitamin-K antagonists vs. NOAC for resolution of left atrial appendage thrombus in patients with atrial fibrillation.

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Atrial Fibrillation - Stroke Prevention Oral Anticoagulation EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Nora Wainstejn

German Heart Institute Berlin, Berlin (Germany)

10 More presentations in this session

Presentation thumbnail
Single-centre experience of percutaneous left atrial appendage closure using the lifetech lambre device for thromboembolic prevention in patients with atrial fibrillation.
Professor K. Neven (Essen, DE)
Abstract Slides
Presentation thumbnail
Perception on anticoagulant treatment and treatment convenience for patients switching from a vitamin K antagonist to dabigatran for stroke prophylaxis in atrial fibrillation (RE-SONANCE study)
Doctor R. Tieleman (Groningen, NL)
Abstract Slides
Presentation thumbnail
Left atrial appendage occlusion using novel lambre, amulet and watchman in atrial fibrillation
Doctor S. Chen (Greifswald, DE)
Abstract
Presentation thumbnail
Thirty-day clinical outcomes after rhythmology procedures in patients with non-valvular atrial fibrillation on apixaban: Results of the AMPER AF study
Professor J. Mansourati (Brest, FR)
Abstract
Presentation thumbnail
Thirty-day clinical outcomes after an atrial flutter ablation in patients on dabigatran: the STUDY FLUTTER French prospective study
Miss D. Mlayeh (Aulnay sous Bois, FR)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Atrial Fibrillation - Stroke Prevention

The Event

Event poster

EHRA 2019

17 March - 19 March 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources